Widmann Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$544K Hold
8,966
0.32% 70
2025
Q4
$484K Buy
8,966
+156
+2% +$7.5K 0.3% 71
2025
Q3
$397K Sell
8,810
-56
-0.6% -$2.62K 0.25% 76
2025
Q2
$410K Hold
8,866
0.29% 70
2025
Q1
$541K Buy
8,866
+910
+11% +$53K 0.42% 58
2024
Q4
$450K Buy
7,956
+370
+5% +$20.7K 0.35% 61
2024
Q3
$393K Sell
7,586
-75
-1% -$3.52K 0.3% 67
2024
Q2
$318K Sell
7,661
-220
-3% -$9.84K 0.26% 69
2024
Q1
$427K Sell
7,881
-200
-2% -$10.2K 0.36% 53
2023
Q4
$415K Sell
8,081
-1,035
-11% -$54.3K 0.37% 52
2023
Q3
$529K Buy
9,116
+800
+10% +$49K 0.53% 52
2023
Q2
$532K Hold
8,316
0.51% 51
2023
Q1
$576K Sell
8,316
-150
-2% -$10.6K 0.58% 50
2022
Q4
$609K Sell
8,466
-26
-0.3% -$1.96K 0.64% 48
2022
Q3
$604K Sell
8,492
-100
-1% -$7.25K 0.67% 50
2022
Q2
$661K Sell
8,592
-120
-1% -$9.14K 0.68% 51
2022
Q1
$636K Buy
8,712
+76
+0.9% +$5.1K 0.56% 50
2021
Q4
$538K Buy
+8,636
New +$507K 0.44% 51

Other funds holding BMY

Widmann Financial Services's BMY Position: Q1 2026 in Review

Widmann Financial Services held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 8,966 shares worth $544K. The position accounts for 0.32% of the portfolio, ranked #70.

Widmann Financial Services first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $661K in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Widmann Financial Services held 8,966 shares of Bristol-Myers Squibb worth $544K as of Q1 2026.
  • Widmann Financial Services left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.32% of Widmann Financial Services's portfolio in Q1 2026, its #70 holding.
  • Widmann Financial Services first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
  • Widmann Financial Services's Bristol-Myers Squibb position peaked at $661K in Q2 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Widmann Financial Services's 13F filing for Q1 2026, filed 15 May 2026.